[ACL] QoQ Quarter Result on 31-Mar-2022 [#Q3]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
30-Mar-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q3]
Profit Trend
QoQ- -81.56%
YoY- 1,355.45%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 360,312 180,156 457,603 228,802 538,001 269,001 328,798 6.27%
PBT 32,756 16,378 69,956 34,978 184,944 92,472 5,379 232.37%
Tax 7,274 3,637 21,842 10,921 54,656 27,328 2,063 131.12%
NP 25,421 12,711 48,030 24,015 130,214 65,107 3,300 288.60%
Tax Rate -22.21% -22.21% -31.22% -31.22% -29.55% -29.55% -38.35% -
Total Cost 334,891 167,446 409,573 204,787 407,787 203,894 325,498 1.90%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 7.06 7.06 10.50 10.50 24.20 24.20 1.00 266.71%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.13 0.06 0.24 0.12 0.65 0.32 0.02 247.10%
EPS Diluted 0.13 0.06 0.24 0.12 0.65 0.32 0.02 247.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.